About Nu Skin Enterprises (NYSE:NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Trailing P/E Ratio22.01
Forward P/E Ratio19.97
Sales & Book Value
Annual Sales$2.28 billion
Price / Sales1.65
Cash Flow$4.7267 per share
Price / Cash15.04
Book Value$13.40 per share
Price / Book5.31
EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Return on Equity25.23%
Return on Assets11.54%
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Friday, February 16th. Stockholders of record on Monday, February 26th will be given a dividend of $0.365 per share on Wednesday, March 14th. This represents a $1.46 annualized dividend and a dividend yield of 2.05%. The ex-dividend date of this dividend is Friday, February 23rd. This is a positive change from Nu Skin Enterprises's previous quarterly dividend of $0.36. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises (NYSE:NUS) announced its quarterly earnings results on Thursday, February, 15th. The company reported $1.20 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.19 by $0.01. The business had revenue of $666.20 million for the quarter, compared to the consensus estimate of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. The company's revenue for the quarter was up 25.4% on a year-over-year basis. During the same period last year, the firm earned $0.79 EPS. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises updated its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share (EPS) guidance of $3.45-3.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.66. The company issued revenue guidance of $2.44-2.49 billion, compared to the consensus revenue estimate of $2.36 billion.Nu Skin Enterprises also updated its Q1 guidance to $0.65-0.70 EPS.
What price target have analysts set for NUS?
6 equities research analysts have issued 1-year price targets for Nu Skin Enterprises' shares. Their forecasts range from $57.00 to $90.00. On average, they expect Nu Skin Enterprises' stock price to reach $70.1667 in the next twelve months. View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. According to Zacks Investment Research, "Nu Skin is a premier anti-aging company. The company's anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system. " (2/28/2018)
- 2. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)
Who are some of Nu Skin Enterprises' key competitors?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 65)
- Mr. Ritch N. Wood, CEO & Director (Age 52)
- Mr. Ryan S. Napierski, Pres (Age 44)
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)
- Mr. D. Matthew Dorny, Exec. VP, Gen. Counsel & Sec. (Age 54)
Has Nu Skin Enterprises been receiving favorable news coverage?
News headlines about NUS stock have been trending somewhat positive this week, according to Accern. The research group rates the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nu Skin Enterprises earned a coverage optimism score of 0.12 on Accern's scale. They also assigned news coverage about the company an impact score of 45.99 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $71.09.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $3.75 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NUS)MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Nu Skin Enterprises (NYSE:NUS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Nu Skin Enterprises in the last 12 months. Their average twelve-month price target is $70.1667, suggesting that the stock has a possible downside of 1.30%. The high price target for NUS is $90.00 and the low price target for NUS is $57.00. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.00||2.17||2.14||2.00|
|Ratings Breakdown: ||2 Sell Rating(s)|
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$70.1667||$70.1667||$63.5714||$60.6667|
|Price Target Upside: ||1.30% downside||0.22% upside||10.26% downside||2.34% downside|
Nu Skin Enterprises (NYSE:NUS) Consensus Price Target History
Nu Skin Enterprises (NYSE:NUS) Analyst Ratings History
(Data available from 4/23/2016 forward)
Nu Skin Enterprises (NYSE:NUS) Dividend Information
Nu Skin Enterprises pays an annual dividend of $1.46 per share, with a dividend yield of 2.05%. NUS's most recent quarterly dividend payment was Wednesday, March 14. The company has grown its dividend for the last 17 consecutive years and is increasing its dividend by an average of 1.40% each year. Nu Skin Enterprises pays out 45.20% of its earnings out as a dividend.
|Most Recent Dividend:||3/14/2018|
|Dividend Growth:||1.40% (3 Year Average)|
|Payout Ratio:||45.20% (Trailing 12 Months of Earnings) |
41.01% (Based on This Year's Estimates)
38.02% (Based on Next Year's Estimates)
|Track Record:||17 Years of Consecutive Dividend Growth|
Nu Skin Enterprises (NYSE:NUS) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Nu Skin Enterprises (NYSE NUS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 76.79%
Nu Skin Enterprises (NYSE NUS) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/4/2018||D Matthew Dorny||General Counsel||Sell||2,000||$75.00||$150,000.00||47,878|| |
|4/4/2018||Steven Lund||Chairman||Sell||81,000||$75.00||$6,075,000.00||4,769|| |
|4/2/2018||D Matthew Dorny||General Counsel||Sell||3,250||$72.22||$234,715.00|| |
|3/9/2018||Mark H Lawrence||CFO||Sell||724||$72.86||$52,750.64||11,473|| |
|3/7/2018||Pisano R Thomas||Director||Sell||15,000||$72.00||$1,080,000.00||47,437|| |
|3/5/2018||D Matthew Dorny||General Counsel||Sell||3,000||$72.69||$218,070.00||44,399|| |
|1/22/2018||Steven Lund||Chairman||Sell||22,891||$70.08||$1,604,201.28||4,769|| |
|1/19/2018||Steven Lund||Chairman||Sell||13,978||$70.01||$978,599.78||4,769|| |
|12/27/2017||Steven Lund||Chairman||Sell||8,977||$70.04||$628,749.08||4,769|| |
|12/22/2017||Steven Lund||Chairman||Sell||108,132||$68.81||$7,440,562.92||4,769|| |
|12/20/2017||Steven Lund||Chairman||Sell||42,000||$68.11||$2,860,620.00||4,769|| |
|11/10/2017||Joseph Y Chang||Insider||Sell||36,503||$62.24||$2,271,946.72||66,563|| |
|11/8/2017||Joseph Y Chang||Insider||Sell||13,497||$62.06||$837,623.82||66,563|| |
|11/1/2017||Ryan S Napierski||President||Sell||11,667||$63.84||$744,821.28||71,634|| |
|10/10/2017||Ryan S Napierski||President||Sell||6,933||$64.00||$443,712.00|| |
|9/7/2017||Daniel W Campbell||Director||Sell||4,607||$62.48||$287,845.36||63,753|| |
|8/10/2017||D Matthew Dorny||General Counsel||Sell||7,500||$60.88||$456,600.00||52,230|| |
|7/25/2017||Ryan S Napierski||President||Sell||8,000||$65.00||$520,000.00||68,170|| |
|7/5/2017||D Matthew Dorny||General Counsel||Sell||8,250||$62.92||$519,090.00||46,730|| |
|6/5/2017||D Matthew Dorny||General Counsel||Sell||8,000||$56.39||$451,120.00||52,730|| |
|5/11/2017||D Matthew Dorny||General Counsel||Sell||8,000||$58.32||$466,560.00||53,730|| |
|4/3/2017||D Matthew Dorny||General Counsel||Sell||8,000||$55.30||$442,400.00||53,730|| |
|3/6/2017||D Matthew Dorny||General Counsel||Sell||16,000||$50.00||$800,000.00||45,730|| |
|2/16/2017||Ryan S Napierski||Insider||Sell||8,400||$55.00||$462,000.00||48,905|| |
|1/6/2017||D Matthew Dorny||General Counsel||Sell||8,000||$50.00||$400,000.00||49,230|| |
|12/13/2016||D Matthew Dorny||General Counsel||Sell||20,000||$50.10||$1,002,000.00||41,230|| |
|10/26/2016||Steven Lund||Chairman||Sell||61,000||$61.55||$3,754,550.00|| |
|9/22/2016||Andrew D Lipman||Director||Sell||30,000||$64.13||$1,923,900.00||36,090|| |
|3/8/2016||Ritch N Wood||CFO||Buy||7,500||$33.32||$249,900.00||50,996|| |
|3/4/2016||Joseph Y Chang||Insider||Sell||20,000||$34.21||$684,200.00||43,613|| |
|8/18/2015||Scott E. Schwerdt||insider||Sell||18,750||$45.96||$861,750.00||34,585|| |
|7/6/2015||Daniel R Chard||Insider||Sell||17,500||$46.67||$816,725.00|| |
|11/26/2014||Ritch N Wood||CFO||Buy||2,500||$43.03||$107,575.00|| |
|11/14/2013||D Matthew Dorny||General Counsel||Sell||20,000||$112.50||$2,250,000.00||30,255|| |
|10/22/2013||Steven Lund||Chairman||Sell||50,000||$117.33||$5,866,500.00|| |
|9/6/2013||Steven Lund||Chairman||Sell||47,000||$86.07||$4,045,290.00|| |
|8/22/2013||Daniel Campbell||Director||Sell||8,203||$86.82||$712,184.46||51,000|| |
|8/21/2013||Patricia Negron||Director||Sell||5,000||$86.20||$431,000.00||7,192|| |
|8/6/2013||Steven Lund||Chairman||Sell||40,000||$87.33||$3,493,200.00||4,053|| |
Nu Skin Enterprises (NYSE NUS) News Headlines
|BRIEF-Nu Skin Enterprises Enters Into A Credit Agreement That Provides For A $400 Million Term Loan Facility|
www.reuters.com - April 23 at 5:22 PM
|Can Solid Sales Endeavors Fuel Nu Skin (NUS) Q1 Earnings?|
www.nasdaq.com - April 23 at 5:22 PM
|Dividend Analysis: Nu Skin Enterprises|
www.msn.com - April 21 at 8:08 AM
| Analysts Expect Nu Skin Enterprises (NUS) Will Announce Quarterly Sales of $561.32 Million|
www.americanbankingnews.com - April 20 at 2:16 AM
|Nu Skin Enterprises (NUS) Expected to Announce Earnings of $0.67 Per Share|
www.americanbankingnews.com - April 18 at 5:12 PM
|Nu Skin Enterprises (NUS) Stock Rating Lowered by BidaskClub|
www.americanbankingnews.com - April 14 at 9:51 PM
|Stifel Nicolaus Analysts Give Nu Skin Enterprises (NUS) a $50.00 Price Target|
www.americanbankingnews.com - April 13 at 9:27 PM
|Nu Skin Enterprises (NUS) Downgraded to "Hold" at Deutsche Bank|
www.americanbankingnews.com - April 13 at 10:37 AM
|Nu Skin Enterprises (NUS) Upgraded to "B" at TheStreet|
www.americanbankingnews.com - April 13 at 10:15 AM
|Stock Traders Purchase Large Volume of Nu Skin Enterprises Put Options (NUS)|
www.americanbankingnews.com - April 12 at 7:01 AM
|Nu Skin Enterprises (NUS) Downgraded by Zacks Investment Research to Sell|
www.americanbankingnews.com - April 7 at 12:39 AM
|Insider Selling: Nu Skin Enterprises (NUS) General Counsel Sells 2,000 Shares of Stock|
www.americanbankingnews.com - April 5 at 10:21 PM
|Steven Lund Sells 81,000 Shares of Nu Skin Enterprises (NUS) Stock|
www.americanbankingnews.com - April 5 at 10:20 PM
|Nu Skin Enterprises (NUS) General Counsel Sells $234,715.00 in Stock|
www.americanbankingnews.com - April 3 at 10:26 PM
|Nu Skin Enterprises (NUS) Upgraded by ValuEngine to Strong-Buy|
www.americanbankingnews.com - April 3 at 11:06 AM
|Nu Skin Enterprises (NUS) Expected to Announce Quarterly Sales of $561.32 Million|
www.americanbankingnews.com - April 3 at 2:44 AM
|$0.67 Earnings Per Share Expected for Nu Skin Enterprises (NUS) This Quarter|
www.americanbankingnews.com - April 1 at 5:10 PM
|Nu Skin Enterprises (NUS) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - April 1 at 3:30 PM
|Nu Skin Enterprises (NUS) Earns "Buy" Rating from Citigroup|
www.americanbankingnews.com - March 26 at 8:46 PM
|Nu Skin Enterprises To Report First-Quarter 2018 Results|
finance.yahoo.com - March 26 at 5:31 PM
| Brokerages Anticipate Nu Skin Enterprises, Inc. (NUS) Will Post Quarterly Sales of $561.32 Million|
www.americanbankingnews.com - March 17 at 7:11 AM
|Nu Skin Enterprises, Inc. (NUS) Expected to Announce Earnings of $0.67 Per Share|
www.americanbankingnews.com - March 15 at 3:54 PM
|Insider Selling: Nu Skin Enterprises, Inc. (NUS) CFO Sells 724 Shares of Stock|
www.americanbankingnews.com - March 12 at 8:18 PM
|Nu Skin Enterprises To Present At Bank Of America Merrill Lynch 2018 Consumer And Retail Technology Conference|
finance.yahoo.com - March 8 at 6:59 PM
|Insider Selling: Nu Skin Enterprises, Inc. (NUS) Director Sells 15,000 Shares of Stock|
www.americanbankingnews.com - March 8 at 6:29 PM
|Nu Skin Enterprises, Inc. (NUS) Receives Consensus Rating of "Hold" from Brokerages|
www.americanbankingnews.com - March 7 at 3:45 PM
|Nu Skin Enterprises, Inc. (NUS) General Counsel D Matthew Dorny Sells 3,000 Shares|
www.americanbankingnews.com - March 6 at 6:50 PM
|Royce & Associates LP Cuts Position in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - March 6 at 10:53 AM
|Traders Purchase Large Volume of Nu Skin Enterprises Call Options (NUS)|
www.americanbankingnews.com - March 6 at 8:29 AM
|See what the IHS Markit Score report has to say about NU Skin Enterprises Inc.|
finance.yahoo.com - March 5 at 5:58 PM
|Nu Skin Enterprises, Inc. (NUS) Holdings Lifted by UBS Asset Management Americas Inc.|
www.americanbankingnews.com - March 5 at 2:42 PM
|BlackRock Inc. Has $464.77 Million Holdings in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - March 3 at 4:46 AM
|Schroder Investment Management Group Decreases Holdings in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - March 2 at 9:58 AM
|BRIEF-Nu Skin Enterprises Says Selling Stockholder To Offer Up To 1.5 Million Shares Of Co's Class A Common Stock|
www.reuters.com - March 1 at 6:01 PM
|Teacher Retirement System of Texas Buys 13,900 Shares of Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - March 1 at 5:36 PM
|First Trust Advisors LP Has $13.12 Million Stake in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - March 1 at 6:42 AM
|Zacks Investment Research Lowers Nu Skin Enterprises (NUS) to Hold|
www.americanbankingnews.com - February 28 at 10:52 AM
|California Public Employees Retirement System Has $11.35 Million Holdings in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - February 28 at 5:24 AM
|$561.32 Million in Sales Expected for Nu Skin Enterprises, Inc. (NUS) This Quarter|
www.americanbankingnews.com - February 28 at 4:32 AM
|Systematic Financial Management LP Reduces Position in Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - February 27 at 4:22 PM
|Swiss National Bank Buys 2,600 Shares of Nu Skin Enterprises, Inc. (NUS)|
www.americanbankingnews.com - February 27 at 4:02 PM
| Analysts Anticipate Nu Skin Enterprises, Inc. (NUS) Will Announce Earnings of $0.67 Per Share|
www.americanbankingnews.com - February 26 at 3:20 PM
|Analyst Recommendations for Herbalife Stock after 4Q17|
finance.yahoo.com - February 26 at 8:06 AM
|Nu Skin Enterprises, Inc. (NUS) Ex-Dividend Date Scheduled for February 23, 2018 - Nasdaq|
www.nasdaq.com - February 23 at 8:06 AM
|Ex-Dividend Alert: Nu Skin Enterprises Boosted its Dividend By 1.5%; Will Trade Ex-Dividend on February 23, 2018|
finance.yahoo.com - February 22 at 8:07 AM
|Notable Tuesday Option Activity: UPS, NUS, STMP - Nasdaq|
www.nasdaq.com - February 21 at 8:08 AM
|Nu Skin Enterprises Sees Unusually High Options Volume (NUS)|
www.americanbankingnews.com - February 20 at 6:56 AM
|Analyst Recommendations for Herbalife before 4Q17|
finance.yahoo.com - February 19 at 8:06 AM
|Deutsche Bank Boosts Nu Skin Enterprises (NUS) Price Target to $77.00|
www.americanbankingnews.com - February 16 at 6:02 PM
|Nu Skin Enterprises, Inc. (NUS) Announces Dividend Increase - $0.37 Per Share|
www.americanbankingnews.com - February 16 at 5:40 PM
Nu Skin Enterprises (NYSE:NUS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Nu Skin Enterprises (NYSE:NUS) Income Statement, Balance Sheet and Cash Flow Statement
Nu Skin Enterprises (NYSE NUS) Stock Chart for Monday, April, 23, 2018